Peptides - Retatrutide
Praha |Pošta: Kolovraty
8 Kč [Praha] Kolovraty

Otočit obrázek
Retatrutide (LY-3437943) is an experimental drug developed by Eli Lilly and Company in the United States for the treatment of obesity. It is a triple glucagon hormone receptor agonist (GLP-1, Global Investment Program, and GCGR receptor)
![]() |
|
![]() |
|
|
|
![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Informace od: jennie xu